⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Anlon Healthcare LimitedAHCL

Anlon Healthcare Limited is an Indian pharmaceutical company focused on the manufacturing and distribution of healthcare products.

Key productsPharmaceuticals, medical devices
GeographyIndia, with regional presence in Southeast Asia
CompetitorsCadila Healthcare, Dr. Reddy's Laboratories

AI-generated overview — verify before relying on it.

Net institutional flow

−₹19.3 Cr

Institutional buyers

5 in / 7 out

High-impact filings

0 · tilt Neutral

Next corporate action

Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share

ex 2026-04-24

Competitive landscape — the read

vs most-traded names · ALL
1M3M6M1Y2YAll
Institutional money is backing ATALREAL hardest (+₹7.2 Cr net). AHCL ranks #7 of 7 on flow (net selling −₹17.9 Cr).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+₹7.2 Cr154————
2MOBIKWIK+₹0.1 Cr83————
3QUADFUTURE+₹0 Cr134————
4MTNL+₹0 Cr2————
5GATECH+₹0 Cr8————
6IRMENERGY−₹2.2 Cr328————
7AHCLThis−₹17.9 Cr4————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Weaknesses

  • • [object Object]
  • • [object Object]

Opportunities

  • • [object Object]
  • • [object Object]

Threats

  • • [object Object]
  • • [object Object]

AI-generated from our data — verify before relying on it.

Timeline — AHCL day by day

1M3M6M1Y2YAll
  1. 2026-06-11FilingAnlon Healthcare Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (LODR) ReUpdates
  2. 2026-06-09BulkSELL · ₹14.4 CrNEOMILE GROWTH FUND-SERIES I
  3. 2026-06-09FilingAnlon Healthcare Limited has informed the Exchange regarding Media Interaction of Chairman & Managing DirectorManagement
  4. 2026-06-09FilingAnlon Healthcare Limited has informed the Exchange about TranscriptInvestor Call
  5. 2026-06-09NetDay net −₹14.4 Cr
  6. 2026-04-24BulkSELL · ₹3.4 CrNEOMILE GROWTH FUND-SERIES I
  7. 2026-04-24ActionFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per ShareSplit
  8. 2026-04-24ActionBonus 1:1Bonus
  9. 2026-04-24NetDay net −₹3.4 Cr
  10. 2026-01-21BulkSELL · ₹5.1 CrNEOMILE CORPORATE ADVISORY LIMITED
  11. 2026-01-21BulkBUY · ₹5 CrNEOMILE GROWTH FUND-SERIES I
  12. 2026-01-21NetDay net −₹0.1 Cr
  13. 2025-11-10BulkSELL · ₹6.5 CrNEOMILE CORPORATE ADVISORY LIMITED
  14. 2025-11-10NetDay net −₹6.5 Cr
  15. 2025-11-04BulkSELL · ₹9.9 CrNEOMILE CORPORATE ADVISORY LIMITED
  16. 2025-11-04NetDay net −₹9.9 Cr
  17. 2025-11-03BulkSELL · ₹23.7 CrNEOMILE CORPORATE ADVISORY LIMITED
  18. 2025-11-03BulkBUY · ₹12.8 CrNEOMILE GROWTH FUND - SERIES I
  19. 2025-11-03NetDay net −₹10.9 Cr
  20. 2025-09-24BulkBUY · ₹4.2 CrRP FAMILY PRIVATE TRUST
  21. 2025-09-24NetDay net +₹4.2 Cr
  22. 2025-09-19BulkBUY · ₹3.4 CrHRTI PRIVATE LIMITED
  23. 2025-09-19BulkSELL · ₹3.6 CrHRTI PRIVATE LIMITED
  24. 2025-09-19BulkSELL · ₹3.5 CrMATHISYS ADVISORS LLP
  25. 2025-09-19BulkBUY · ₹3.8 CrMATHISYS ADVISORS LLP
  26. 2025-09-19BulkBUY · ₹6.8 CrRP FAMILY PRIVATE TRUST
  27. 2025-09-19NetDay net +₹6.9 Cr
  28. 2025-09-18BulkSELL · ₹6.8 CrHRTI PRIVATE LIMITED
  29. 2025-09-18BulkBUY · ₹7.2 CrHRTI PRIVATE LIMITED
  30. 2025-09-18BulkSELL · ₹4.5 CrMATHISYS ADVISORS LLP
  31. 2025-09-18BulkBUY · ₹4.5 CrMATHISYS ADVISORS LLP
  32. 2025-09-18NetDay net +₹0.4 Cr
  33. 2025-09-17BulkSELL · ₹4.2 CrHRTI PRIVATE LIMITED
  34. 2025-09-17BulkBUY · ₹5 CrHRTI PRIVATE LIMITED
  35. 2025-09-17NetDay net +₹0.8 Cr
  36. 2025-09-11BulkBUY · ₹7.8 CrNEOMILE CORPORATE ADVISORY LIMITED
  37. 2025-09-11NetDay net +₹7.8 Cr
  38. 2025-09-10BulkSELL · ₹3.6 CrNEOMILE CORPORATE ADVISORY LIMITED
  39. 2025-09-10BulkBUY · ₹7.2 CrNEOMILE CORPORATE ADVISORY LIMITED
  40. 2025-09-10NetDay net +₹3.6 Cr
  41. 2025-09-09BulkSELL · ₹1.5 CrNEOMILE CORPORATE ADVISORY LIMITED
  42. 2025-09-09BulkBUY · ₹7.9 CrNEOMILE CORPORATE ADVISORY LIMITED
  43. 2025-09-09NetDay net +₹6.4 Cr
  44. 2025-09-03BulkBUY · ₹6.4 CrASCENT WEALTH
  45. 2025-09-03BulkBUY · ₹18.4 CrNEOMILE CORPORATE ADVISORY LIMITED
  46. 2025-09-03BulkBUY · ₹18.2 CrNEOMILE GROWTH FUND - SERIES I
  47. 2025-09-03BulkSELL · ₹14.4 CrNOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONE
  48. 2025-09-03BulkSELL · ₹8.2 CrPINE OAK GLOBAL FUND - CLASS B
  49. 2025-09-03NetDay net +₹20.4 Cr

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

  • 2
    UpdatesNeutral

    Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 Invitation for TV Interview on NDTV Profit.'.

    Source PDF →
  • 2
    ManagementNeutral

    No significant share-price impact expected from media interaction disclosure.

    Source PDF →
  • 2
    Investor CallNeutral

    Transcript

    Source PDF →

Bulk & block deals

1M3M6M1Y2YAll

30 deals · 2025-09-03 → 2026-06-09

DateCounterpartyTypeSideValue
2026-06-09NEOMILE GROWTH FUND-SERIES IInstitutionSELL₹14.4 Cr
2026-04-24NEOMILE GROWTH FUND-SERIES IInstitutionSELL₹3.4 Cr
2026-01-21NEOMILE CORPORATE ADVISORY LIMITEDInstitutionSELL₹5.1 Cr
2026-01-21NEOMILE GROWTH FUND-SERIES IInstitutionBUY₹5 Cr
2025-11-10NEOMILE CORPORATE ADVISORY LIMITEDInstitutionSELL₹6.5 Cr
2025-11-04NEOMILE CORPORATE ADVISORY LIMITEDInstitutionSELL₹9.9 Cr
2025-11-03NEOMILE CORPORATE ADVISORY LIMITEDInstitutionSELL₹23.7 Cr
2025-11-03NEOMILE GROWTH FUND - SERIES IInstitutionBUY₹12.8 Cr
2025-09-24RP FAMILY PRIVATE TRUSTInstitutionBUY₹4.2 Cr
2025-09-19HRTI PRIVATE LIMITEDProp / churnBUY₹3.4 Cr

30 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

Results & transcripts

Financial results

None yet.

News & chatter on AHCL

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.